SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-026673
Filing Date
2011-02-08
Accepted
2011-02-08 08:38:12
Documents
6
Period of Report
2011-02-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 26675
2 UNDERWRITING AGREEMENT dex11.htm EX-1.1 176050
3 FORM OF WARRANT dex41.htm EX-4.1 74971
4 OPINION OF PILLSBURY WINTHROP SHAW PITTMAN LLP dex51.htm EX-5.1 5911
5 PRESS RELEASE dex991.htm EX-99.1 10651
6 GRAPHIC g148494g67s88.jpg GRAPHIC 17260
  Complete submission text file 0001193125-11-026673.txt   320050
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 11580466
SIC: 2834 Pharmaceutical Preparations